Data as of Sep 13, 2026. Both funds on the fields they both publish, from the same sources.
IBB vs RDVY: how they differ
IBB and RDVY hold 0% of their weight in the same names, and IBB returned more over the year.
iShares Biotechnology ETF and First Trust Rising Dividend Achievers ETF.
What they hold in common
By the books each fund has filed, IBB and RDVY hold 0% of their money in the same securities at the same weight.
| Only in IBB | Only in RDVY |
|---|---|
| VERTEX PHARMACEUTICALS 7.94% | Lam Research Corporation 3.09% |
| AMGEN INC 7.85% | Applied Materials, Inc. 2.99% |
| GILEAD SCIENCES 7.44% | KLA Corporation 2.47% |
| REGENERON PHARMACEUTICALS 5.92% | The Bank of New York Mellon Corporation 2.46% |
| ARGENX SE ADR 3.78% | The Travelers Companies, Inc. 2.26% |
| MODERNA 3.67% | GE Vernova Inc. 2.24% |
| NATERA 3.30% | Bank of America Corporation 2.18% |
| REVOLUTION MEDICINES 2.87% | Ross Stores, Inc. 2.16% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 10, 2026.
| IBB iShares Biotechnology ETF | RDVY First Trust Rising Dividend Achievers ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | First Trust |
| What it is | Biotechnology | First Rising Dividend Achievers |
| Total return, 1 year | +41.5% | +22.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +24.0 pts | +4.5 pts |
| Expense ratio | 0.44% | 0.47% |
| Already in the S&P 500 | 35.6% | 94.4% |
| Holdings | 233 | 72 |
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Sep 10, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 233 positions, with the top ten at 47.5%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
RDVY in plain words
RDVY is an index equity fund tracking the First Rising Dividend Achievers. Over the year to Sep 11, 2026 it returned +22.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.47% a year. By its holdings filed for Sep 10, 2026, 94% of the fund by weight is stocks the S&P 500 also holds, across 72 positions, with the top ten at 24.1%. It sat 3.9% below its high of Aug 13, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IBB or RDVY?
- In the year to Sep 13, 2026, with distributions reinvested, IBB returned +41.5% and RDVY returned +22.0%, so IBB returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IBB or RDVY?
- IBB charges 0.44% a year and RDVY charges 0.47%, so IBB is cheaper. Fees come from each fund's prospectus.
- How much do IBB and RDVY overlap with the S&P 500?
- By their latest filed holdings, 36% of IBB and 94% of RDVY by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IBB against RDVY, data as of Sep 13, 2026. https://etfiq.com/compare/any/ibb-vs-rdvy Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources